@article{ATM12247,
author = {Sergio Amaro and Laura Llull},
title = {Preclinical randomized controlled multicenter trials in translational stroke research},
journal = {Annals of Translational Medicine},
volume = {4},
number = {Suppl 1},
year = {2016},
keywords = {},
abstract = {Natalizumab is a humanized monoclonal antibody against alpha-4 integrin (CD49d) that reduces the incursion of circulating leukocytes into the central nervous system across the endothelium (1).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/12247}
}